To include your compound in the COVID-19 Resource Center, submit it here.

FDA panel unanimously backs telaprevir

FDA's Antiviral Drugs Advisory Committee voted 18-0 to recommend approval of telaprevir from Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) to treat HCV. The panel members were impressed by the efficacy of telaprevir. In

Read the full 319 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE